Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Scherer

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Physiological Reports|October 9, 2023
Transcriptomic analysis reveals partial epithelial-mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathyOle Petter Nordbø, Lea Landolt, Øystein Eikrem, et al.
Nephron|January 9, 2016
Proteomic Analysis of Minimally Damaged Renal Tubular Tissue from Two-Kidney-One-Clip Hypertensive Rats Demonstrates Extensive Changes Compared to Tissue from ControlsKenneth Finne, Hans-Peter Marti, Sabine Leh, et al.
Plos One|February 23, 2016
Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker DevelopmentOystein Eikrem, Christian Beisland, Karin Hjelle, et al.
Pharmaceutical Research|August 9, 2005
VeloceGenomics: an accelerated in vivo drug discovery approach to rapidly predict the biologic, drug-like activity of compounds, proteins, or genesRuben Papoian, Andreas Scherer, Muriel Saulnier, et al.
Journal of Hypertension|October 12, 2014
Distinct protein signature of hypertension-induced damage in the renal proteome of the two-kidney, one-clip rat modelHeidrun Vethe, Kenneth Finne, Trude Skogstrand, et al.
Cancer Cell International|December 21, 2021
AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing diseaseSigrid Nakken, Øystein Eikrem, Hans-Peter Marti, et al.
BMC Medical Genomics|July 2, 2013
Alteration of human blood cell transcriptome in uremiaAndreas Scherer, Oliver P Günther, Robert F Balshaw, et al.
Experimental Dermatology|June 29, 2011
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroidsJens-Michael Jensen, Kerstin Ahrens, Josef Meingassner, et al.
Scientific Reports|August 5, 2022
A multiomics disease progression signature of low-risk ccRCCPhilipp Strauss, Mariell Rivedal, Andreas Scherer, et al.
International Journal of Molecular Sciences|March 15, 2018
Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell CarcinomaPhilipp Strauss, Hans-Peter Marti, Christian Beisland, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Physiological Reports|October 9, 2023
Transcriptomic analysis reveals partial epithelial-mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathyOle Petter Nordbø, Lea Landolt, Øystein Eikrem, et al.
Nephron|January 9, 2016
Proteomic Analysis of Minimally Damaged Renal Tubular Tissue from Two-Kidney-One-Clip Hypertensive Rats Demonstrates Extensive Changes Compared to Tissue from ControlsKenneth Finne, Hans-Peter Marti, Sabine Leh, et al.
Plos One|February 23, 2016
Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker DevelopmentOystein Eikrem, Christian Beisland, Karin Hjelle, et al.
Pharmaceutical Research|August 9, 2005
VeloceGenomics: an accelerated in vivo drug discovery approach to rapidly predict the biologic, drug-like activity of compounds, proteins, or genesRuben Papoian, Andreas Scherer, Muriel Saulnier, et al.
Journal of Hypertension|October 12, 2014
Distinct protein signature of hypertension-induced damage in the renal proteome of the two-kidney, one-clip rat modelHeidrun Vethe, Kenneth Finne, Trude Skogstrand, et al.
Cancer Cell International|December 21, 2021
AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing diseaseSigrid Nakken, Øystein Eikrem, Hans-Peter Marti, et al.
BMC Medical Genomics|July 2, 2013
Alteration of human blood cell transcriptome in uremiaAndreas Scherer, Oliver P Günther, Robert F Balshaw, et al.
Experimental Dermatology|June 29, 2011
Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroidsJens-Michael Jensen, Kerstin Ahrens, Josef Meingassner, et al.
Scientific Reports|August 5, 2022
A multiomics disease progression signature of low-risk ccRCCPhilipp Strauss, Mariell Rivedal, Andreas Scherer, et al.
International Journal of Molecular Sciences|March 15, 2018
Expanding the Utilization of Formalin-Fixed, Paraffin-Embedded Archives: Feasibility of miR-Seq for Disease Exploration and Biomarker Development from Biopsies with Clear Cell Renal Cell CarcinomaPhilipp Strauss, Hans-Peter Marti, Christian Beisland, et al.
Pageof 6